Creates inhaled anti-inflammatory medications to treat chronic, severe respiratory disorders.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Kinaset Therapeutics operates as a clinical-stage biotechnology company focused on researching and advancing novel respiratory treatments. The pharmaceutical firm primarily engineers non-invasive, dry-powder inhaled anti-inflammatory therapies that selectively inhibit pathway kinases to address unmet clinical needs in patients suffering from severe asthma and chronic obstructive pulmonary disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Kinaset Therapeutics Management Team
Kinaset Therapeutics Valuations & Financials
View real-time NPM data on Kinaset Therapeutics stock including daily Kinaset Therapeutics stock price estimates, valuation history, and historical share price information. Access Kinaset Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Kinaset Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Kinaset Therapeutics? Get in touch to learn more.
Similar Companies
like Kinaset Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Restream
Media & Entertainment
Platform enabling simultaneous live video broadcasting across multiple social media channels with streaming, scheduling and analytics tools.
Akeyless
Pioneers a zero-knowledge identity security platform that unifies vaultless secrets management, machine identity tracking, and just-in-time privileged access to eliminate infrastructure overhead and protect credentials across hybrid cloud ecosystems.
Trialspark
Healthcare & Life Sciences
Tech-driven pharmaceutical company accelerates drug development by acquiring clinical-stage treatments and optimizing their path to market.
BirdEye
Provides a platform that transforms customer feedback into actionable insights and marketing tools for reputation and experience management.
Empyrean Neuroscience
Healthcare & Life Sciences
Biotech firm engineers fungi and plant genomes to develop therapeutic compounds targeting neurological and psychiatric disorders.
MP2
Enables businesses to embed banking, lending, and payment capabilities into their products through API-driven platforms.
ClearFlame
Climate & Sustainability
Develops technology to convert diesel engines to run on renewable fuels, reducing emissions while maintaining performance for heavy-duty applications.
Goodcover
Delivers a digital, cooperative renters insurance platform, utilizing a fixed-fee model that returns unused premium money to members as an annual dividend.
FAQ
We have answers
Kinaset Therapeutics stock does not trade on public stock exchanges. Kinaset Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Kinaset Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Kinaset Therapeutics Stock does not trade on public stock exchanges. In order to sell Kinaset Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Kinaset Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Kinaset Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Kinaset Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Kinaset Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Kinaset Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Kinaset Therapeutics is a private company and has not had an IPO. There is currently no Kinaset Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Kinaset Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
